MedPath
NMPA Approval

Raltitrexed for Injection

国药准字H20244205

June 28, 2024

Drug Information

注射用雷替曲塞

注射剂

2mg

化学药品

June 28, 2024

Company Information

Applicant Company

山东省德州市齐河县晏北街道办事处齐众大道127号

Manufacturing Company

山西省大同经济技术开发区第一医药园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用雷替曲塞 - NMPA 批准文号 | MedPath